A US Food and Drug Administration (FDA) pooled analysis of outcomes for bone only metastatic breast cancer (MBC).

被引：0
|
作者：
Wedam, Suparna B.
Beaver, Julia A.
Amiri-Kordestani, Laleh
Bloomquist, Erik
Tang, Shenghui
Sridhara, Rajeshwari
Ibrahim, Amna
Kim, Geoffrey
Kluetz, Paul Gustav
McKee, Amy E.
Pazdur, Richard
机构：
[1] US FDA, Silver Spring, MD USA
[2] US FDA, Bethesda, MD 20014 USA
[3] US FDA, Kensington, MD USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.570
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
570
引用
收藏
页数：2
相关论文
共 50 条
  • [1] US Food and Drug Administration Pooled Analysis to Assess the Impact of Bone-Only Metastatic Breast Cancer on Clinical Trial Outcomes and Radiographic Assessments
    Wedam, Suparna B.
    Beaver, Julia A.
    Amiri-Kordestani, Laleh
    Bloomquist, Erik
    Tang, Shenghui
    Goldberg, Kirsten B.
    Sridhara, Rajeshwari
    Ibrahim, Amna
    Kim, Geoffrey
    Kluetz, Paul
    McKee, Amy
    Pazdur, Richard
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (12) : 1225 - +
  • [2] Association of clinical benefit rate (CBR) with survival: A pooled-analysis of metastatic breast cancer (MBC) trials submitted to the US Food and Drug Administration (FDA)
    Amiri-Kordestani, Laleh
    Cheng, Joyce
    Zhang, Lijun
    Tang, Shenghui
    Sridhara, Rajeshwari
    Ibrahim, Amna
    Kim, Geoffrey
    McKee, Amy E.
    Pazdur, Richard
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [3] US Food and Drug Administration Approval Overview in Metastatic Breast Cancer
    Cortazar, Patricia
    Justice, Robert
    Johnson, John
    Sridhara, Rajeshwari
    Keegan, Patricia
    Pazdur, Richard
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (14) : 1705 - 1711
  • [4] Metastatic breast cancer (MBC): FDA approval overview
    Cortazar, P.
    Johnson, J. R.
    Justice, R.
    Pazdur, R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [5] Benefit of CDK 4/6 inhibition in less common breast cancer subsets: A US Food and Drug Administration pooled analysis
    Gao, Jennifer J.
    Cheng, Joyce
    Bloomquist, Erik
    Schroeder, Robert
    Amiri-Kordestani, Laleh
    Sridhara, Rajeshwari
    Blumenthal, Gideon Michael
    Pazdur, Richard
    Beaver, Julia A.
    Prowell, Tatiana Michelle
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [6] A US food and drug administration pooled analysis of outcomes of older women with hormone-receptor positive metastatic breast cancer treated with a CDK4/6 inhibitor as initial endocrine based therapy
    Singh, Harpreet
    Howie, Lynn J.
    Bloomquist, Erik
    Wedam, Suparna
    Amiri-Kordestani, Laleh
    Tang, Shengui
    Sridhara, Rajeshwari
    Ibrahim, Amna
    Goldberg, Kirsten
    Mckee, Amy
    Beaver, Julia A.
    Pazdur, Richard
    [J]. CANCER RESEARCH, 2018, 78 (04)
  • [7] National comprehensive cancer network (NCCN) recommendations for drugs without US food and drug administration (FDA) approval in metastatic breast cancer: A cross-sectional study
    Etan, Tal
    Amir, Eitan
    Tibau, Adriana
    Yerushalmi, Rinat
    Moore, Assaf
    Shepshelovich, Daniel
    Goldvaser, Hadar
    [J]. CANCER RESEARCH, 2021, 81 (04)
  • [8] TRENDS OF METASTATIC LEIOMYOSARCOMA FOLLOWING THE US FOOD AND DRUG ADMINISTRATION (FDA) WARNING ON LAPAROSCOPIC POWER MORCELLATORS
    Eakin, Cortney
    Liao, Cheng-I
    Cohen, Joshua
    Salani, Ritu
    Kapp, Daniel
    Chan, John K.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2022, 32 : A8 - A8
  • [9] US Food and Drug Administration's (FDA) safety assessment of food ingredients
    Thurmond, Scott
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 245
  • [10] Overall survival in patients with breast cancer treated with a CDK 4/6 inhibitor plus fulvestrant: A US Food and Drug Administration pooled analysis.
    Gao, Jennifer J.
    Cheng, Joyce
    Prowell, Tatiana Michelle
    Bloomquist, Erik
    Tang, Shenghui
    Wedam, Suparna B.
    Royce, Melanie E.
    Krol, Danielle
    Osgood, Christy
    Ison, Gwynn
    Sridhara, Rajeshwari
    Pazdur, Richard
    Beaver, Julia A.
    Amiri-Kordestani, Laleh
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
12345